开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
据华尔街日报:美国总统特朗普宣称场馆“座无虚席”,但实际上有许多空位。
2026-09-10
据华尔街日报:美国总统特朗普宣称场馆“座无虚席”,但实际上有许多空位。
返回
其他消息
2026-09-10
After Apple’s Sept. 10 fall event, the company website lists only iPhone Air, iPhone 17, iPhone 17e and iPhone 16 for sale; the iPhone 17 Pro series has been removed. Apple customer service said the 17 Pro line is taken down when new products arrive and will not be relisted, leaving only base models on sale. Customers were advised to check stock at Apple retail stores or search online for remaining availability.
After Apple’s Sept. 10 fall event, the company website lists only iPhone Air, iPhone 17, iPhone 17e and iPhone 16 for sale; the iPhone 17 Pro series has been removed. Apple customer service said the 17 Pro line is taken down when new products arrive and will not be relisted, leaving only base models on sale. Customers were advised to check stock at Apple retail stores or search online for remaining availability.
2026-09-10
Novo Nordisk (NVO.N) said its long-acting growth hormone injection, marketed in China as NuozeYou, received approval for three additional pediatric indications: growth retardation associated with Noonan syndrome in children aged 2.5 years and older; idiopathic short stature in children aged 2.5 years and older; and children born small for gestational age who remain short at age 2, for treatment in patients aged 2.5 years and older. The product was previously approved in China for pediatric growt
Novo Nordisk (NVO.N) said its long-acting growth hormone injection, marketed in China as NuozeYou, received approval for three additional pediatric indications: growth retardation associated with Noonan syndrome in children aged 2.5 years and older; idiopathic short stature in children aged 2.5 years and older; and children born small for gestational age who remain short at age 2, for treatment in patients aged 2.5 years and older. The product was previously approved in China for pediatric growth hormone deficiency.
Chat with us
, powered by
LiveChat